EU regulators approve plasma device from Cytomedix

12/12/2012 | MassDevice.com (Boston)

Cytomedix has earned CE mark approval in Europe for use of its Angel concentrated platelet-rich plasma technology with bone marrow aspirate. The system, which was cleared by the FDA last month, includes adjustable settings to allow customized processing and preparation of plasma in clinical settings or at the point of care.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA